Correlation Between Cue Biopharma and Instil Bio
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Instil Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Instil Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Instil Bio, you can compare the effects of market volatilities on Cue Biopharma and Instil Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Instil Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Instil Bio.
Diversification Opportunities for Cue Biopharma and Instil Bio
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cue and Instil is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Instil Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instil Bio and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Instil Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instil Bio has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Instil Bio go up and down completely randomly.
Pair Corralation between Cue Biopharma and Instil Bio
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the Instil Bio. But the stock apears to be less risky and, when comparing its historical volatility, Cue Biopharma is 1.04 times less risky than Instil Bio. The stock trades about -0.13 of its potential returns per unit of risk. The Instil Bio is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 3,177 in Instil Bio on September 1, 2024 and sell it today you would lose (486.00) from holding Instil Bio or give up 15.3% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Cue Biopharma vs. Instil Bio
Performance |
Timeline |
Cue Biopharma |
Instil Bio |
Cue Biopharma and Instil Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cue Biopharma and Instil Bio
The main advantage of trading using opposite Cue Biopharma and Instil Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Instil Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instil Bio will offset losses from the drop in Instil Bio's long position.Cue Biopharma vs. Tff Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics | Cue Biopharma vs. Inhibrx | Cue Biopharma vs. Enliven Therapeutics |
Instil Bio vs. Cue Biopharma | Instil Bio vs. Tff Pharmaceuticals | Instil Bio vs. Eliem Therapeutics | Instil Bio vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |